about
Molecular Evidence of Chlamydia-Like Organisms in the Feces of Myotis daubentonii Bats.Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trial.Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes.Mortality and causes of death among women with a history of placental abruption.Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.Long-term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening.Porphyromonas gingivalis may interfere with conception in women.Foley catheter induction of labor as an outpatient procedure.Amniotic fluid rapid biomarkers are associated with intra-amniotic infection in preterm pregnancies regardless of the membrane status.Foley Catheter or Oral Misoprostol for Induction of Labor in Women with Term Premature Rupture of Membranes: A Randomized Multicenter Trial.Vaginally obtained amniotic fluid samples in the diagnosis of subclinical chorioamnionitis.Long-term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening.Risk of preterm birth in women with cervical intraepithelial neoplasia grade one: a population-based cohort study.Predicting tubal factor infertility by using markers of humoral and cell-mediated immune response against Chlamydia trachomatisCervical and Amniotic Fluid Matrix Metalloproteinase-8 and Interleukin-6 Concentrations in Preterm Pregnancies with or without Preterm Premature Rupture of MembranesGender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)Serum antibody response to Chlamydia trachomatis TroA and HtrA in women with tubal factor infertilityBacterial Vaginosis and Desquamative Inflammatory VaginitisPlacental Abruption and Child MortalityPredictive Values of Serum Chlamydia trachomatis TroA and HtrA IgG Antibodies as Markers of Persistent Infection in the Detection of Pelvic Adhesions and Tubal OcclusionAmniotic fluid and umbilical cord serum erythropoietin in term and prolonged pregnanciesEradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policiesHigh risk in the first-trimester combined screening: Long-term outcomes of the childrenThe Prevalence of HSV, HHV-6, HPV and Mycoplasma genitalium in Chlamydia trachomatis positive and Chlamydia trachomatis Negative Urogenital Samples among Young Women in FinlandSubsequent risk of cancer among women with a history of placental abruptionTranscriptional Expression of the ompA, cpaf, tarp, and tox Genes of Chlamydia trachomatis Clinical Isolates at Different Stages of the Developmental CycleMajor or minor placenta previa: Does it make a difference?
P50
Q37546872-25883E14-E21A-4AB7-84D0-5134B5A3BD86Q37561432-B7472370-25B7-434E-AE3B-C6234D9DE496Q37607347-E6A27AD0-7418-4CC2-91C8-FB485033BFB3Q38612403-CFD244C0-9B4D-4A8F-83AA-A692A4F0DC19Q38618078-852D0736-3DC5-467D-86DB-606ACB0B18F8Q39966230-0988782B-CA53-4D03-B500-7A024ACCBBCEQ40117974-7F708F5C-8D17-4C71-A6DE-D26862B3B37BQ40714619-FCF97EE3-FEDF-440F-9F58-AE58AC7290C0Q40724581-E8128A49-B8BF-4F4D-AEB4-C537E7F40483Q40734612-128A644A-E0ED-40EB-A936-794E6BACFCE0Q40950001-95BED586-FC71-4235-96A3-E20A3886364FQ41685484-AD1DF0AE-8948-450C-9F3B-41E46A595275Q47428688-B73C9C76-B219-4203-B7D0-DA30683F8115Q57033196-849A88DF-59DE-47E3-9B8E-1E78ED44A1E2Q57280563-87F81B59-82F2-4817-9551-91611D217DC5Q59360234-C0E8E60A-621E-4770-8940-B4AE248E85B3Q60769286-D193C127-9AB2-41F1-9499-E959E69A3FEEQ61772633-D5FCBC0E-3697-4E87-B9C1-4C620E0D898AQ90007287-8077174B-DE58-41A4-A49D-F97D07BE53F4Q90310503-11378DE2-1779-464B-A7E9-120F6FA87FA6Q90356991-F05A6F7B-DD45-4EE5-A261-B48930D370DEQ91108208-4494AE3C-BA19-4971-BCBD-A675BE326AC5Q91569310-AA8AF060-9BC7-403A-8F46-5B2C3C2DDFC7Q91726398-D06A52A7-391E-495A-8486-970FBD9BCC8CQ91840810-EEBBE6A4-238E-451C-A9C4-1B059D27951AQ92376527-FF698C10-6FE2-40C4-857E-17D61C339E57Q92673603-815C69E1-2440-493F-A7A6-34FA3481026D
P50
description
researcher
@en
wetenschapper
@nl
name
J Paavonen
@en
J Paavonen
@nl
type
label
J Paavonen
@en
J Paavonen
@nl
prefLabel
J Paavonen
@en
J Paavonen
@nl
P31
P496
0000-0003-4775-606X